MENU
+Compare
OCX
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$2.65
Change
-$0.07 (-2.57%)
Capitalization
24.2M

OCX Oncocyte Corp Forecast, Technical & Fundamental Analysis

a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer

OCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OCX with price predictions
Feb 21, 2025

Aroon Indicator for OCX shows an upward move is likely

OCX's Aroon Indicator triggered a bullish signal on February 21, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 105 similar instances where the Aroon Indicator showed a similar pattern. In of the 105 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 10, 2025. You may want to consider a long position or call options on OCX as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OCX just turned positive on January 30, 2025. Looking at past instances where OCX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

OCX moved above its 50-day moving average on February 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OCX crossed bullishly above the 50-day moving average on February 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCX advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OCX moved out of overbought territory on February 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OCX broke above its upper Bollinger Band on February 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.658) is normal, around the industry mean (23.448). P/E Ratio (4.558) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (14.451) is also within normal values, averaging (41.230).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
OCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
15 Cushing
Phone
+1 949 409-7600
Employees
76
Web
https://www.oncocyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHC7.310.13
+1.81%
Bausch Health Companies
GRC39.14-0.62
-1.56%
Gorman-Rupp Company (The)
MTB193.53-3.92
-1.99%
M&T Bank Corp
ANGO10.33-0.26
-2.46%
AngioDynamics
HKIT1.26-0.04
-3.08%
Hitek Global

OCX and Stocks

Correlation & Price change

A.I.dvisor tells us that OCX and FATE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OCX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCX
1D Price
Change %
OCX100%
-2.57%
FATE - OCX
31%
Poorly correlated
-8.09%
GOSS - OCX
29%
Poorly correlated
-8.50%
BMRN - OCX
29%
Poorly correlated
-0.70%
CRIS - OCX
28%
Poorly correlated
N/A
AXON - OCX
28%
Poorly correlated
-5.28%
More